Related references
Note: Only part of the references are listed.Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells
Xuexin Feng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
The Ascension of Targeted Covalent Inhibitors
Juswinder Singh
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs
Maxime Liberelle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells
Shiyan Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Rational design and chemical modification of TEAD coactivator peptides to target hippo signaling pathway against gastrointestinal cancers
Shuxia Gao et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2021)
Structure-based derivation and optimization of YAP-like coactivator-derived peptides to selectively target TEAD family transcription factors by hydrocarbon stapling and cyclization
Bo He et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors
Manon Sturbaut et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands
John Bowen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors
Yi Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma
Jacquelyn T. Saunders et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy
Chenglong Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine
Evan R. Barry et al.
CELLS (2021)
Small-Molecule Inhibitors Targeting the Canonical WNT Signaling Pathway for the Treatment of Cancer
Zhiqing Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction
Zhen Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
Tracy T. Tang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
YAP-dependent proliferation by a small molecule targeting annexin A2
Sophia Z. Shalhout et al.
NATURE CHEMICAL BIOLOGY (2021)
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
Tian Lu et al.
ACTA PHARMACEUTICA SINICA B (2021)
Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation
Keisuke Nakatani et al.
CANCER SCIENCE (2021)
Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic Acid
Lea Melin et al.
CHEMMEDCHEM (2021)
Design, Synthesis and Evaluation of a Series of 1,5-Diaryl-1,2,3-triazole-4-carbohydrazones as Inhibitors of the YAP-TAZ/TEAD Complex
Floriane Gibault et al.
CHEMMEDCHEM (2021)
Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction
Zilu Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions
Shiyan Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders
Stefano Tomassi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues
Nathaniel Kastan et al.
NATURE COMMUNICATIONS (2021)
Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery
Jongwan Kim et al.
CANCERS (2021)
IK-930 mediated TEAD inhibition decreases and delays tumor growth and enhances targeted apoptosis in lung and colon cancer xenografts when combined with MEK or EGFR inhibitors
Benjamin Amidon et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation
Shixuan Liu et al.
SCIENCE (2021)
Hot-Spots of Mcl-1 Protein
Camille Denis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of FAM181A and FAM181B as new interactors with the TEAD transcription factors
Fedir Bokhovchuk et al.
PROTEIN SCIENCE (2020)
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa et al.
CANCER CELL (2020)
YAP-dependent necrosis occurs in early stages of Alzheimer's disease and regulates mouse model pathology
Hikari Tanaka et al.
NATURE COMMUNICATIONS (2020)
Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein-Protein Interaction
Yong Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics
Verena B. K. Kunig et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
The Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases
Jiayan Jin et al.
FRONTIERS IN NEUROSCIENCE (2020)
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Jeffrey K. Holden et al.
CELL REPORTS (2020)
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket
Hacer Karatas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors
Yannick Mesrouze et al.
SCIENTIFIC REPORTS (2020)
Recent Advances in the Development of PD-L1 Modulators: Degraders, Downregulators, and Covalent Inhibitors
Binbin Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A protein tertiary structure mimetic modulator of the Hippo signalling pathway
Helene Adihou et al.
NATURE COMMUNICATIONS (2020)
Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways
Xiaomin Dang et al.
RESPIRATORY RESEARCH (2020)
Identification of a Covalent Molecular Inhibitor of Anti-apoptotic BFL-1 by Disulfide Tethering
Edward P. Harvey et al.
CELL CHEMICAL BIOLOGY (2020)
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications
Zhihong Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells
Shannon M. White et al.
DEVELOPMENTAL CELL (2019)
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
Nicolas Figeac et al.
JOURNAL OF CELL SCIENCE (2019)
Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence
Pascal Furet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Safety Considerations in the Development of Hippo Pathway Inhibitors in Cancers
Satoko Kakiuchi-Kiyota et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Identification of Quinolinols as Activators of TEAD-Dependent Transcription
Ajaybabu V. Pobbati et al.
ACS CHEMICAL BIOLOGY (2019)
Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ-TEAD Biosensors
Kazem Nouri et al.
CANCERS (2019)
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors
Wenchao Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
Sarah A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine
Ivan M. Moya et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
New Therapeutic Approach for Targeting Hippo Signalling Pathway
Leticia Dominguez-Berrocal et al.
SCIENTIFIC REPORTS (2019)
Targeting Transcriptional Enhanced Associate Domains (TEADs)
Floriane Gibault et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4
Yan Li et al.
BIOCHEMICAL JOURNAL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Pathogenesis of non-alcoholic fatty liver disease mediated by YAP
Ping Chen et al.
HEPATOLOGY INTERNATIONAL (2018)
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma
Ping-Chih Hsu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
Jakob S. Pallesen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
YAP and TAZ are dispensable for physiological and malignant haematopoiesis
Elisa Donato et al.
LEUKEMIA (2018)
Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor
Edward P. Harvey et al.
STRUCTURE (2018)
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
Min Hwan Kim et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Toward the Discovery of a Novel Class of YAP-TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP-TEAD Protein-Protein Interface
Floriane Gibault et al.
CANCERS (2018)
Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
Jeffrey K. Holden et al.
CANCERS (2018)
Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface
Yannick Mesrouze et al.
PROTEIN SCIENCE (2018)
Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells
Kaly A. Mueller et al.
SCIENTIFIC REPORTS (2018)
Repurposing of Drugs Targeting YAP-TEAD Functions
Gian Marco Elisi et al.
CANCERS (2018)
Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway
Zhiqiang Li et al.
CANCER CELL (2018)
Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review
James J. Crawford et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Effects of 3-Bromo-4,5-dihydroisoxazole Derivatives on Nrf2 Activation and Heme Oxygenase-1 Expression
Andrea Pinto et al.
CHEMISTRYOPEN (2018)
The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer
Ping-Chih Hsu et al.
BIOMEDICINES (2018)
Active epithelial Hippo signaling in idiopathic pulmonary fibrosis
Jason J. Gokey et al.
JCI INSIGHT (2018)
Regulatory T cells in cancer immunotherapy
Atsushi Tanaka et al.
CELL RESEARCH (2017)
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Paul A. Jackson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis
Ming Liang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches
Hung Yi Kristal Kaan et al.
PLOS ONE (2017)
Regulation of the Hippo Pathway Transcription Factor TEAD
Kimberly C. Lin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
Hung Yi Kristal Kaan et al.
SCIENTIFIC REPORTS (2017)
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Noa Furth et al.
CELL DEATH AND DIFFERENTIATION (2017)
Inspired by Nature: The 3-Halo-4,5-dihydroisoxazole Moiety as a Novel Molecular Warhead for the Design of Covalent Inhibitors
Andrea Pinto et al.
CHEMMEDCHEM (2016)
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
E. Ciamporcero et al.
ONCOGENE (2016)
Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells
Haiying Cheng et al.
ONCOTARGET (2016)
MST1/MST2 Protein Kinases: Regulation and Physiologic Roles
Jacob A. Galan et al.
BIOCHEMISTRY (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
Yahui Ding et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Stephen G. Szeto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway
PuiYee Chan et al.
NATURE CHEMICAL BIOLOGY (2016)
Small molecules, big targets: drug discovery faces the protein-protein interaction challenge
Duncan E. Scott et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling
Cameron L. Noland et al.
STRUCTURE (2016)
A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation
Yangfan Qi et al.
NATURE COMMUNICATIONS (2016)
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Fei Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies
Renato A. Bauer
DRUG DISCOVERY TODAY (2015)
Structure-based inhibition of protein-protein interactions
Andrew M. Watkins et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease
Mariana Verdelho Machado et al.
JOURNAL OF HEPATOLOGY (2015)
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
Matteo Santucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas
Ji-Eun Oh et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Hippo Pathway Gene Mutations in Malignant Mesothelioma Revealed by RNA and Targeted Exon Sequencing
Akihiko Miyanaga et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy
Ajaybabu V. Pobbati et al.
STRUCTURE (2015)
Two-signal requirement for growth-promoting function of Yap in hepatocytes
Tian Su et al.
ELIFE (2015)
Covalent Modification of a Cysteine Residue in the XPB Subunit of the General Transcription Factor TFIIH Through Single Epoxide Cleavage of the Transcription Inhibitor Triptolide
Qing-Li He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
Yujun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells
M. Bartucci et al.
ONCOGENE (2015)
Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer
Tian Yu et al.
PROTEIN & CELL (2015)
A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
Shi Jiao et al.
CANCER CELL (2014)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
Wenjing Zhang et al.
CELL RESEARCH (2014)
A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis
Qian Chen et al.
GENES & DEVELOPMENT (2014)
YAP and TAZ Regulate Skin Wound Healing
Min-Jung Lee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
Cornelius Kloeck et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Promiscuity and Selectivity in Covalent Enzyme Inhibition: A Systematic Study of Electrophilic Fragments
Christian Joest et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
B. Mao et al.
ONCOGENE (2014)
Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma
Weiying Zhang et al.
SCIENCE SIGNALING (2014)
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction
Zhisen Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Emerging roles of TEAD transcription factors and its coactivators in cancers
Ajaybabu V. Pobbati et al.
CANCER BIOLOGY & THERAPY (2013)
Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2
Feng Yin et al.
CELL (2013)
The TEAD4-YAP/TAZ Protein-Protein Interaction: Expected Similarities and Unexpected Differences
Jean Christophe Hau et al.
CHEMBIOCHEM (2013)
The Tumor Suppressor Mst1 Promotes Changes in the Cellular Redox State by Phosphorylation and Inactivation of Peroxiredoxin-1 Protein
Sonali Jalan Rawat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Making of I-BET762, a BET Bromodomain Inhibitor Now in Clinical Development
Yujun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
NF2 Genetic Alterations in Sporadic Vestibular Schwannomas
Luis Lassaletta et al.
OTOLOGY & NEUROTOLOGY (2013)
Yap- and Cdc42-Dependent Nephrogenesis and Morphogenesis during Mouse Kidney Development
Antoine Reginensi et al.
PLOS GENETICS (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Yes-associated protein regulates the hepatic response after bile duct ligation
Haibo Bai et al.
HEPATOLOGY (2012)
Structure of the Stapled p53 Peptide Bound to Mdm2
Sohee Baek et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Gilson S. Baia et al.
MOLECULAR CANCER RESEARCH (2012)
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation
A. Fernandez-L et al.
ONCOGENE (2012)
Tumor suppressor Hippo/MST1 kinase mediates chemotaxis by regulating spreading and adhesion
Yulia Artemenko et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Ajaybabu V. Pobbati et al.
STRUCTURE (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation
Karin Schlegelmilch et al.
CELL (2011)
Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance
Dawang Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Chad A. Hall et al.
CANCER RESEARCH (2010)
The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals
Nailing Zhang et al.
DEVELOPMENTAL CELL (2010)
The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program
Jing Cai et al.
GENES & DEVELOPMENT (2010)
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Liming Chen et al.
GENES & DEVELOPMENT (2010)
Structural insights into the YAP and TEAD complex
Ze Li et al.
GENES & DEVELOPMENT (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates
Corinne Faucheux et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2010)
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Hai Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Functional inactivation of NF2/merlin in human mesothelioma
Claudio Thurneysen et al.
LUNG CANCER (2009)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
The Neurofibromatosis 2 Tumor Suppressor Gene Product, Merlin, Regulates Human Meningioma Cell Growth by Signaling through YAP
Katherine Striedinger et al.
NEOPLASIA (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates α1-adrenergic activation of gene expression in cardiac myocytes
HH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
Functional proteomics of the active cysteine protease content in drosophila S2 cells
C Kocks et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
Mammalian vestigial-like 2, a cofactor of TEF-1 and MEF2 transcription factors that promotes skeletal muscle differentiation
T Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Proteasome inhibitors: from research tools to drug candidates
AF Kisselev et al.
CHEMISTRY & BIOLOGY (2001)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
Share Paper
